Company Profile
Genprex Stock Price, News & Analysis
- Ticker:
- GNPX
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
4.44 USD (0.00%)
Close
Last updated: August 6, 2026
7.78M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, GNPX was little changed and closed at $4.44. No new same-company headline was identified in the current news window.
Company overview
Business overview
Genprex is a gene-therapy and oncology company focused on cancer and diabetes-related programs. Its platform has long centered on genetic medicine in difficult disease settings.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Genprex sits in specialty biotechnology.
Business Model Characteristics
The company depends on platform validation, clinical progress, and the ability to translate gene-delivery science into value.
Position Within the Biotechnology Landscape
Genprex is a high-catalyst genetic-medicine name with strong dependence on early results.
Future catalysts
Genprex’s catalysts are the oncology and diabetes platforms, plus any strategic update that shows the company can still create value. The market needs a more convincing clinical path.
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Genprex (GNPX)?
Genprex (GNPX) most recently closed at 4.44 USD, a 0.00% move versus the previous session.
What is the market cap of Genprex (GNPX)?
Genprex currently has a market capitalization of 7.78M USD on BioPharmSignal.
What does Genprex do?
Genprex is a gene-therapy and oncology company focused on cancer and diabetes-related programs. Its platform has long centered on genetic medicine in difficult disease settings.
On which exchange is GNPX stock listed?
Genprex (GNPX) is associated with NASDAQ, United States, Biopharma.
What is Genprex?
Genprex’s catalysts are the oncology and diabetes platforms, plus any strategic update that shows the company can still create value.
Which conditions is Genprex targeting with Genprex?
Genprex is associated with oncology, cancer therapeutics, diabetes based on its company overview and current catalyst commentary.
How does Genprex describe recent progress with Genprex?
Genprex’s catalysts are the oncology and diabetes platforms, plus any strategic update that shows the company can still create value.
What future catalysts are investors watching for Genprex?
Genprex’s catalysts are the oncology and diabetes platforms, plus any strategic update that shows the company can still create value. The market needs a more convincing clinical path.